Drug intelligence / Profile preview

Liuzhenbao Oral Liquid

Development stage: Preclinical
Lead developer: Changshu Leiyunshang Pharmaceutical
Administration: Oral

Overview

Liuzhenbao Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed by Lei Yun Shang. It is an oral herbal formulation currently under research and development by the Lei Yunshang Group Institute of Chinese Medicine. As a TCM product, its therapeutic effects are derived from a complex mixture of herbal ingredients rather than a single molecular target. It is part of a broader 'Liuzhenbao' product line that includes other formulations such as gels and capsules. While specific indications were not detailed on the company's primary R&D page, it is positioned within their pipeline of proprietary TCM research projects.

Brand names: Liuzhenbao
Other names: 六珍宝口服液Liuzhenbao-Lei Yun Shang-Traditional Chinese Medicine (oral liquid)-oral

Beyond the preview

Go deeper on Liuzhenbao Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liuzhenbao Oral Liquid.

Explore the full profile